Design of Y2 Receptor Selective and Proteolytically Stable PYY3-36 Analogues

J Med Chem. 2018 Dec 13;61(23):10519-10530. doi: 10.1021/acs.jmedchem.8b01046. Epub 2018 Nov 20.

Abstract

In recent years peptide YY (PYY) has attracted attention within the area of diabetes and obesity due to its involvement in food intake regulation and glucose homeostasis. It is well-known that PYY1-36 is rapidly cleaved by dipeptidyl peptidase-4 to the more Y2 receptor selective analogue PYY3-36, which is further cleaved to the inactive analogue PYY3-34. In order to improve the selectivity and proteolytic stability of the C-terminus, we synthesized several analogues incorporating N-methyl amino acids or β-homo amino acids and other non-natural amino acids. These were tested against all four NPY receptors, and highly potent and Y2 receptor selective analogues were identified by combining a tryptophan residue in position 30 with either N-methyl or β-homo arginine in position 35. We also identified an analogue with a MeGln34 substitution that surprisingly displayed high affinity toward all four receptors. In addition, these analogues displayed improved stability toward C-terminal proteolysis compared to native PYY3-36.

MeSH terms

  • Amino Acid Sequence
  • HEK293 Cells
  • Humans
  • Models, Molecular
  • Peptide YY / chemistry*
  • Peptide YY / metabolism*
  • Protein Conformation, beta-Strand
  • Protein Stability
  • Proteolysis
  • Receptors, Neuropeptide Y / metabolism*
  • Substrate Specificity

Substances

  • Receptors, Neuropeptide Y
  • Peptide YY